This is unpublished

ASCEND: A Trial of Sertraline vs. CBT for End-Stage Renal Disease Patients with Depression

Completed Studies
CKD
Dialysis
Pinned
Principal Investigator
Rajnish Mehrotra
Funding Agency
PCORI
Patient Centered Outcomes Research Institute: CER-1310*07253
Status
Completed

Investigator

Rajnish Mehrotra, MD

 

 

 

Rajnish Mehrotra, MD, MS

What is the Ascend Study?

The ASCEND study looks at ways to help hemodialysis patients who have depression, either through cognitive-behavioral therapy during their dialysis sessions or via drug therapy with sertraline.

Publications

 

"Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND)"

[clinicaltrials.gov - Registration number: NCT02358343] 


 

"Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial"